http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016190798-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea6c094eb988e6315eed8f17b50e7af6 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-02 |
filingDate | 2015-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ef921fe90b8b843b96b5c628ec5eb69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b048e09d87889d0bba5610589b49f713 |
publicationDate | 2016-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2016190798-A |
titleOfInvention | Topical nasal drops for the treatment of allergic rhinitis |
abstract | Disclosed is a topical nasal drop for treating steroidal allergic rhinitis, which has an antiallergic effect comparable to that of ciclesonide and has a lower risk of local side effects than ciclesonide. By using a compound in which desisobutyryl ciclesonide and glucose are combined, it has an antiallergic effect comparable to that of ciclesonide and has a lower risk of local side effects than ciclesonide, which is steroidal allergic. It relates to topical nasal drops for the treatment of rhinitis. [Selection figure] None |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10772970-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10668167-B2 |
priorityDate | 2015-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 110.